Pathophysiological, immunological, and inflammatory features of long COVID

Karen Bohmwald1,2†Benjamín Diethelm-Varela1†Linmar Rodríguez-Guilarte1, et. al. Front. Immunol., 27 February 2024, Volume 15 - 2024, https://doi.org/10.3389/fimmu.2024.1341600 The COVID-19 pandemic continues to cause severe global disruption, resulting in significant excess mortality,…[...]

Read More

The Prevalence of Dizziness and Vertigo in COVID-19 Patients: A Systematic Review

George Korres,1,* Dimitrios K. Kitsos,2 Diego Kaski,3 et. al. Abstract Clinical manifestations of COVID-19 include symptoms of vertigo and dizziness, which is rather unsurprising, since SARS-CoV-2 neurotropism may inflict a broad spectrum of…[...]

Read More

Long-Term Taste and Smell Outcomes After COVID-19

Ryan Sharetts, BS1,2; Shima T. Moein, MD, PhD1,2; Rafa Khan, BS1; et alRichard L. Doty, PhD1, JAMA Netw Open. 2024;7(4):e247818. doi:10.1001/jamanetworkopen.2024.7818 Key Points Question  What is the association of COVID-19 with long-term outcomes in taste and smell function as measured by state-of-the-art psychophysical…[...]

Read More

A Unique Case of Unprovoked Pulmonary Venous Thrombosis in a Postpartum Female Following COVID-19 Infection

Jordan Lipschutz • Sophia H. Ji • Mohammad Q. Jafri • Ambica Nair • Brian Kerr, 2024, DOI: 10.7759/cureus.64893 Abstract SARS-CoV-2 can induce a hypercoagulable state, occasionally resulting in pulmonary venous thrombosis (PVT) due to inflammation and endothelial injury.…[...]

Read More

Efficacy and safety of hyperbaric oxygen therapy for long COVID: a protocol for systematic review and meta-analysis

Yuxin Li, Jingnan Lin, Jiazhu Gao et. al., http://orcid.org/0009-0000-2874-1861 Abstract Introduction There is still a lack of therapeutic options for long COVID. Several studies have shown the benefit of hyperbaric oxygen therapy (HBOT) on…[...]

Read More